USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Image-guided Therapy Market, Global, 2024-2029
Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth
18-Oct-2024
Global
Market Research
PFOJ-01-00-00-00
HC_2024_1074
$4,950.00
Special Price $4,207.50 save 15 %
The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In addition, the IGT market is influenced by technological innovations in MRI, CT, molecular imaging, ultrasound, and interventional X-ray during oncology, cardiology, neurosurgery, orthopedic, and urology procedures. The integration of the aforementioned medical imaging modalities with navigation systems and robotics has enabled higher precision and accuracy during surgical procedures.
Frost & Sullivan expects IGT to sustain steady growth during the next 5 years, fueled by increasing expenditures and investments in research and development that drive market expansion. Frost & Sullivan also expects minimally invasive procedures to see higher adoption than conventional surgical procedures, which will propel IGT market growth.
The study period is from 2022 to 2029, the base year is 2024, and the forecast period is from 2025 to 2029. The study analyzes the North American, European, Asia-Pacific, and Rest of World markets, focusing on current scenarios, drivers and restraints, the latest technologies, and notable participants.
Frost & Sullivan segments the IGT market into the following categories:
- Product type:
- Capital equipment
- Medical devices and consumables
- Solutions
- Clinical applications: oncology, cardiology, neurosurgery, urology, and orthopedics
Scope of Analysis
Segmentation
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the IGT Industry
Definition
IGT as a Cross-modality Convergence
Image Guidance by Therapeutic Modalities
Key IGT Solutions
IGT Service Provider Types
Developments in Clinical Application Areas
Competitive Environment
Key Competitors
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Considerations
Forecast Considerations (continued)
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast by Region
Revenue Forecast by Clinical Applications
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Revenue Share
Revenue Share Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast by Clinical Applications
Forecast Analysis
Forecast Analysis (continued)
Federal Regulations for Radiology Solutions, Including IGT Solutions
Competitive Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast by Clinical Applications
Forecast Analysis
Forecast Analysis (continued)
GDPR for Radiology Solutions, Including IGT Solutions
Competitive Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast by Clinical Applications
Forecast Analysis
Medical Tourism as an Opportunity for the IGT Market
Competitive Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast by Clinical Applications
Forecast Analysis
Competitive Analysis
Treatment Options for Oncology
Organ-specific Image-guided Radiotherapy andRadiosurgery
Radiation Therapy—Overview
Image-guided Brachytherapy (IGBT)—Overview
Intraoperative Brachytherapy (IOBT) Procedures
Company Spotlight: Elekta’s Offerings for Oncology
Major Treatment Options for Cardiology
Use of IXR Suites in Cardiology
X-ray-guided IVUS Procedures
Company Spotlight: Boston Scientific Corporation’s Offerings for Cardiology
Treatment Options for Neurology
Roadmaps for Neurology Treatment
Company Spotlight: Koninklijke Philips N.V.’s Neuro Biplane Interventional System
IGT—Urology Interventions
Company Spotlight: GE HealthCare ’s bkActiv for Urology Intervention
IGT—Orthopedic Interventions
Company Spotlight: Ziehm Imaging GmbH’s Offerings for Orthopedic Interventions
Growth Opportunity 1: Real-world Data for Image-guided Therapy
Growth Opportunity 1: Real-world Data for Image-guided Therapy (continued)
Growth Opportunity 2: Using Image-guided High-intensity Focused Ultrasound in Multimodal Imaging
Growth Opportunity 2: Using Image-guided High-intensity Focused Ultrasound in Multimodal Imaging (continued)
Growth Opportunity 3: Minimally Invasive Procedures in APAC
Growth Opportunity 3: Minimally Invasive Procedures in APAC (continued)
Growth Opportunity 4: Integration of AI-based Solutions with Cloud-based Platforms to Manage Large Volumes of Surgical Data
Growth Opportunity 4: Integration of AI-based Solutions with Cloud-based Platforms to Manage Large Volumes of Surgical Data (continued)
Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- IGT: Growth Metrics, Global, 2024
- IGT: Growth Drivers, Global, 2025–2029
- IGT: Growth Restraints, Global, 2025–2029
- IGT: Revenue Forecast, Global, 2022–2029
- IGT: Revenue Forecast by Product Type, Global, 2022–2029
- IGT: Revenue Forecast by Region, Global, 2022–2029
- IGT: Revenue Forecast by Clinical Applications, Global, 2022–2029
- IGT: Revenue Share of Top Participants, Global, 2024
- IGT: Growth Metrics, North America, 2024
- IGT: Revenue Forecast, North America, 2022–2029
- IGT: Revenue Forecast by Product Type, North America, 2022–2029
- IGT: Revenue Forecast by Clinical Applications, North America, 2022–2029
- IGT: Growth Metrics, Europe, 2024
- IGT: Revenue Forecast, Europe, 2022–2029
- IGT: Revenue Forecast by Product Type, Europe, 2022–2029
- IGT: Revenue Forecast by Clinical Applications, Europe, 2022–2029
- IGT: Growth Metrics, APAC, 2024
- IGT: Revenue Forecast, APAC, 2022–2029
- IGT: Revenue Forecast by Product Type, APAC, 2022–2029
- IGT: Revenue Forecast by Clinical Applications, APAC, 2022–2029
- IGT: Growth Metrics, RoW, 2024
- IGT: Revenue Forecast, RoW, 2022–2029
- IGT: Revenue Forecast by Product Type, RoW, 2022–2029
- IGT: Revenue Forecast by Clinical Applications, RoW, 2022–2029
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Anannya Sinha |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | image-guided therapy market |
| Keyword 2 | Image-guided Therapy Systems Market |
| Keyword 3 | image-guided radiation therapy market |
| List of Charts and Figures | IGT: Growth Metrics, Global, 2024~ IGT: Growth Drivers, Global, 2025–2029~ IGT: Growth Restraints, Global, 2025–2029~ IGT: Revenue Forecast, Global, 2022–2029~ IGT: Revenue Forecast by Product Type, Global, 2022–2029~ IGT: Revenue Forecast by Region, Global, 2022–2029~ IGT: Revenue Forecast by Clinical Applications, Global, 2022–2029~ IGT: Revenue Share of Top Participants, Global, 2024~ IGT: Growth Metrics, North America, 2024~ IGT: Revenue Forecast, North America, 2022–2029~ IGT: Revenue Forecast by Product Type, North America, 2022–2029~ IGT: Revenue Forecast by Clinical Applications, North America, 2022–2029~ IGT: Growth Metrics, Europe, 2024~ IGT: Revenue Forecast, Europe, 2022–2029~ IGT: Revenue Forecast by Product Type, Europe, 2022–2029~ IGT: Revenue Forecast by Clinical Applications, Europe, 2022–2029~ IGT: Growth Metrics, APAC, 2024~ IGT: Revenue Forecast, APAC, 2022–2029~ IGT: Revenue Forecast by Product Type, APAC, 2022–2029~ IGT: Revenue Forecast by Clinical Applications, APAC, 2022–2029~ IGT: Growth Metrics, RoW, 2024~ IGT: Revenue Forecast, RoW, 2022–2029~ IGT: Revenue Forecast by Product Type, RoW, 2022–2029~ IGT: Revenue Forecast by Clinical Applications, RoW, 2022–2029~ |
| Podcast | No |
| Predecessor | MD4E-01-00-00-00 |
| WIP Number | PFOJ-01-00-00-00 |